It also suppresses appetite, leading to better weight loss
Initially developed for glycemic control in T2DM, GLP-1 RAs act as incretin mimetics by stimulating glucose-dependent insulin secretion and inhibiting glucagon release (Brunton and Wysham, 2020
Oliver Sum-Ping, MD, a Clinical Associate Professor of Psychiatry and Sleep Medicine at Stanford Medicine who wasnt affiliated with the research told Healthline, The results suggest substantial potential for the role of these medications for at least mitigating OSA. The SURMOUNT-OSA trial was a multi-center, randomized, double-blind, placebo-controlled trial conducted with 469 patients, all of whom had OSA
Stimulates muscle satellite cells to proliferate and differentiate, supporting muscle repair, hypertrophy, and the creation of new muscle fibers for enhanced growth capacity
Para minimizar estos efectos, se recomienda comenzar con una dosis baja y aumentarla progresivamente , permitiendo que el cuerpo se adapte al